Effect of Estrogen Replacement and Calcitonin Therapies on Bone Around Titanium Implants Placed in Ovariectomized Rats: A Histometric Study

International Journal of Oral and Maxillofacial Implants

Volumn 17, Issue 6, 2002, Pages 786-792

  Nociti Jr , Francisco Humberto ^a,b   Sallum, Antonio Wilson ^a   Sallum, Enilson Antonio ^a   Duarte, Poliana Mendes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Calcitonin; Dental implants; Estrogen deficiency; Hormone replacement therapy; Titanium

Indexed keywords

CALCITONIN; ESTRADIOL; ESTROGEN; TITANIUM;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL MODEL; ARTICLE; BONE REGENERATION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; IMPLANT; NONPARAMETRIC TEST; OVARIECTOMY; OVARY; PHYSIOLOGY; RAT; TIBIA; TOOTH IMPLANTATION; WISTAR RAT; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; BONE REGENERATION; CALCITONIN; DENTAL IMPLANTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; IMPLANTS, EXPERIMENTAL; MODELS, ANIMAL; OSSEOINTEGRATION; OVARIECTOMY; OVARY; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TIBIA; TITANIUM; WOUND HEALING;

EID: 0036833681     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brånemark P-I. Osseointegration and its experimental background. J Prosthet Dent 1983;50:390-410.
2. Lindquist LW, Carlsson GE. Long-term effects on chewing with mandibular fixed prostheses on osseointegrated implants. Acta Odontol Scand 1985;43:39-45.
3. Albrektsson T, Zarb GA, Worthington P, Ericsson AR. The long-term efficacy of currently used dental implants: A review and proposed criteria for success. Int J Oral Maxillofac Implants 1986;1:11-25.
4. Zarb GA, Schmitt A. The longitudinal clinical effectiveness of osseointegrated dental implants: The Toronto study. Part II: The prosthetic results. J Prosthet Dent 1990;64:53-61.
5. Esposito M, Hirsch J-M, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants (II). Etiopathogenesis. Eur J Oral Sci 1998;106: 721-764.
6. Harrison JE. Osteoporosis. In: Tam CS, Heersche JNM, Murray TM (eds). Metabolic Bone Diseases: Cellular and Tissue Mechanisms. Boca Raton: CRC Press, 1989:240-267.
7. Dao TTT, Anderson JD, Zarb GA. Is osteoporosis a risk factor for osseointegration of dental implants? Int J Oral Maxillofac Implants 1993;8:137-144.
8. Motohashi M, Shirota T, Tokugawa Y, Ohno K, Michi K, Yamagushi A. Bone reactions around hydroxyapatite-coated implants in ovariectomized rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:145-152.
9. Yamazaki M, Shirota T, Tokugawa Y, et al. Bone reactions to titanium screw implants in ovariectomized animals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87: 411-418.
10. Pan J, Shirota T, Ohno K, Mich K. Effect of ovariectomy on bone remodeling adjacent to hydroxyapatita-coated implants in the tibia of mature rats. J Oral Maxillofac Surg 2000;58: 877-882.
11. Chachra D, Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas MD. The effect of different hormone replacement therapy regimens on the mechanical properties of rat vertebrae. Calcif Tissue Int 1995;56:130-134.
12. Sims NA, Morris HA, Moore RJ, Durbridge TC. Estradiol treatment transiently increases trabecular bone volume in ovariectomized rats. Bone 1996;19:455-461.
13. Wronski TJ, Dann LM, Qi H, Yen C-F. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 1993;53:210-216.
14. Wronski TJ, Yen C-F, Burton KW, et al. Skeletal effects of calcitonin in ovariectomized rats. Endocrinology 1991;129: 2246-2250.
15. Wronski TJ, Schenck PA, Cintron M, Walsh CC. Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 1987;40:155-159.
16. Donath K, Breuner GA. A method for the study of undecalcified bones and teeth with attached soft tissue. J Oral Pathol 1992;11:318-326.
17. Ismail F, Epstein S, Fallon MD, Thomas SB, Reihardt TA. Serum bone Gla protein and the vitamin D endocrine system in the oophorectomized rat. Endocrinology 1988;122: 624-630.
18. Vinco L, Prallet B, Chappard D, Pallot-Prades B, Pupier R, Alexandre C. Contributions of chronological age, age at menarche and menopause and of anthropometric parameters to axial and peripheral bone densities. Osteoporosis Int 1992;2:153-158.
19. Cooper C, Melton LJ III. Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J (eds). Osteoporosis. San Diego: Academic Press, 1996: 419-434.
20. Fujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with osteoporosis: A case report. Int J Oral Maxillofac Implants 1996;11:539-542.
21. Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 1998;338:485-492.
22. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-1514.
23. González D, Ghiringhell G, Mautalen C. Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women. Calcif Tissue Int 1986;38:71-75.
24. Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, Tsekoura M. Analgesic effect of salmon calcitonin on osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study. Calcif Tissue Int 1991;49:369-372.
25. Messer HH, Copp DH. Changes in response to calcitonin following prolonged administration to intact rats. Proc Soc Exp Biol Med 1974;146:643-647.
26. Wada S, Udagawa N, Nagata N, Martin TJ, Findlay DM. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology 1996;137:312-320.
27. Kanis JA. Estrogens, the menopause, and osteoporosis. Bone 1996;19:185S-190S.
28. Shen Y, Li M, Wronski TJ. Skeletal effects of calcitonin treatment and withdrawal in ovariectomized rats. Calcif Tissue Int 1996;58:263-267.